Royalty Pharma PLC (RPRX)

46.57 -0.45  -0.96% NASDAQ Feb 26, 20:00 USD
View Full Chart
Price Chart
View All RPRX News

News

View All Events

Events

Date Type Description
05/17/2021 Earnings Royalty Pharma PLC First Quarter Earnings Results for 2021
05/17/2021 08:00 EDT Misc Royalty Pharma PLC First Quarter Earnings Conference Call for 2021
02/18/2021 Dividends Amount: 0.17, Declared Date: Jan 08 2021, Pay Date: Mar 15 2021
02/17/2021 Earnings Royalty Pharma PLC Fourth Quarter Earnings Result for 2020
02/17/2021 08:00 EST Misc Royalty Pharma PLC Fourth Quarter Earnings Conference Call for 2020
11/19/2020 Dividends Amount: 0.15, Declared Date: Oct 15 2020, Pay Date: Dec 15 2020
11/11/2020 Earnings Royalty Pharma PLC Third Quarter Earnings Result for 2020
11/11/2020 08:00 EST Misc Royalty Pharma PLC Third Quarter Earnings Conference Call for 2020
09/14/2020 Dividends Amount: 0.15, Declared Date: Sep 02 2020, Pay Date: Sep 30 2020
08/12/2020 08:00 EDT Misc Royalty Pharma PLC Second Quarter Earnings Conference Call for 2020
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • URL: https://www.royaltypharma.com
  • Investor Relations URL: N/A
  • HQ State/Province: New York
  • Sector: Healthcare
  • Industry: Biotechnology
  • Equity Style: Mid Cap/Blend
  • Next Earnings Release: May. 17, 2021
  • Last Earnings Release: Feb. 17, 2021
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: Feb. 18, 2021
  • Description: Royalty Pharma PLC is a buyer of biopharmaceutical royalties and a funder of innovation across the biopharmaceutical industry. The company's portfolio consists of royalties on more than 45 marketed therapies and four development-stage product candidates. The therapies in portfolio address therapeutic areas such as rare diseases, oncology, neurology, HIV, cardiology and diabetes, and are delivered to patients across both primary and specialty care settings.

Top Fund Holders

Symbol Name Weighting
MIGLX Morgan Stanley Inst Global Advtg L 4.53%
XPH SPDR® S&P Pharmaceuticals ETF 4.40%
JSMD Janus Henderson Small/Md Cp Gr Alpha ETF 2.88%
TCPWX Transamerica Capital Growth R6 2.41%
MSKLX Morgan Stanley Inst Discovery L 2.36%
MAPLX Morgan Stanley Inst Advantage L 2.14%
FXH First Trust Health Care AlphaDEX® ETF 1.83%
FTQGX Fidelity® Focused Stock 1.65%
IBB iShares Nasdaq Biotechnology ETF 1.45%
IHE iShares US Pharmaceuticals ETF 1.44%
USGIX USAA Growth & Income Class A 1.37%
IPO Renaissance IPO ETF 1.18%

Comparables

Edit
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.